A neoadjuvant approach to esophageal cancer

M. M. DeCamp*, D. J. Sugarbaker

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Patients with symptomatic esophageal cancer represent a significant challenge to the thoracic clinician, whether medical oncologist, surgeon, or radiation therapist. Historically, cure has been rare and palliation has been a more realistic goal. Surgery was often viewed as radical or risky as limited long-term survival was weighed against expected operative morbidity and mortality. Epidermoid tumors were minimally responsive to available chemotherapy. Primary radiotherapy achieved similar overall survival; however, recurrent dysphagia limited its palliative benefit.

Original languageEnglish (US)
Pages (from-to)216S-217S
Issue number6 SUPPL.
StatePublished - 1995

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'A neoadjuvant approach to esophageal cancer'. Together they form a unique fingerprint.

Cite this